|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB: Hepatocellular carcinoma:
recent trends in the United States. Gastroenterology. 127(Suppl 1):
S27–S34. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Minguez B and Lachenmayer A: Diagnostic
and prognostic molecular markers in hepatocellular carcinoma. Dis
Markers. 31:181–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM, Ricci S, Mazzaferro V, et al:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miki D, Ochi H, Hayes CN, Aikata H and
Chayama K: Hepatocellular carcinoma: towards personalized medicine.
Cancer Sci. 103:846–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herath NI, Leggett BA and MacDonald GA:
Review of genetic and epigenetic alterations in
hepatocarcinogenesis (Review). J Gastroenterol Hepatol. 21:15–21.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Villanueva A, Newell P, Chiang DY,
Friedman SL and Llovet JM: Genomics and signaling pathways in
hepatocellular carcinoma. Semin Liver Dis. 27:55–76. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shiraha H, Yamamoto K and Namba M: Human
hepatocyte carcinogenesis (Review). Int J Oncol. 42:1133–1138.
2013.PubMed/NCBI
|
|
10
|
Bird A: Perceptions of epigenetics.
Nature. 447:396–398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khare S, Zhang Q and Ibdah JA: Epigenetics
of hepatocellular carcinoma: role of microRNA. World J
Gastroenterol. 19:5439–5445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanda M, Nomoto S, Okamura Y, et al:
Detection of metallothionein 1G as a methylated tumor suppressor
gene in human hepatocellular carcinoma using a novel method of
double combination array analysis. Int J Oncol. 35:477–483.
2009.PubMed/NCBI
|
|
13
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanda M, Nomoto S, Nishikawa Y, et al:
Correlations of the expression of vascular endothelial growth
factor B and its isoforms in hepatocellular carcinoma with
clinico-pathological parameters. J Surg Oncol. 98:190–196. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takami H, Kanda M, Oya H, et al:
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in
Japanese patients. J Surg Oncol. 108:557–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho JW, Kim JJ, Park SG, et al:
Identification of B-cell translocation gene 1 as a biomarker for
monitoring the remission of acute myeloid leukemia. Proteomics.
4:3456–3463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin WJ, Gary JD, Yang MC, Clarke S and
Herschman HR: The mammalian immediate-early TIS21 protein and the
leukemia-associated BTG1 protein interact with a protein-arginine
N-methyltransferase. J Biol Chem. 271:15034–15044. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rouault JP, Rimokh R, Tessa C, et al:
BTG1, a member of a new family of antiproliferative genes. EMBO J.
11:1663–1670. 1992.PubMed/NCBI
|
|
19
|
Prévôt D, Voeltzel T, Birot AM, et al: The
leukemia-associated protein Btg1 and the p53-regulated protein Btg2
interact with the homeoprotein Hoxb9 and enhance its
transcriptional activation. J Biol Chem. 275:147–153. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Gou WF, Chen S, Takano Y, Xiu YL
and Zheng HC: BTG1 expression correlates with the pathogenesis and
progression of ovarian carcinomas. Int J Mol Sci. 14:19670–19680.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheng SH, Zhao CM and Sun GG: BTG1
expression correlates with the pathogenesis and progression of
breast carcinomas. Tumour Biol. 35:3317–3326. 2014. View Article : Google Scholar
|
|
22
|
Kanda M, Nomoto S, Okamura Y, et al:
Promoter hypermethylation of fibulin 1 gene is associated with
tumor progression in hepatocellular carcinoma. Mol Carcinog.
50:571–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nomoto S, Kanda M, Okamura Y, et al:
Epidermal growth factor-containing fibulin-like extracellular
matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in
hepatocellular carcinoma using double combination array analysis.
Ann Surg Oncol. 17:923–932. 2010. View Article : Google Scholar
|
|
24
|
Okamura Y, Nomoto S, Kanda M, et al:
Reduced expression of reelin (RELN) gene is associated with high
recurrence rate of hepatocellular carcinoma. Ann Surg Oncol.
18:572–579. 2011. View Article : Google Scholar
|
|
25
|
Kanda M, Knight S, Topazian M, et al:
Mutant GNAS detected in duodenal collections of secretin-stimulated
pancreatic juice indicates the presence or emergence of pancreatic
cysts. Gut. 62:1024–1033. 2013. View Article : Google Scholar
|
|
26
|
Kanda M, Matthaei H, Wu J, et al: Presence
of somatic mutations in most early-stage pancreatic intraepithelial
neoplasia. Gastroenterology. 142:730–733. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanda M, Sadakari Y, Borges M, et al:
Mutant TP53 in duodenal samples of pancreatic juice from patients
with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol
Hepatol. 11:719–730. 2013. View Article : Google Scholar :
|
|
28
|
Hibino S, Kanda M, Oya H, et al: Reduced
expression of DENND2D through promoter hypermethylation is an
adverse prognostic factor in squamous cell carcinoma of the
esophagus. Oncol Rep. 31:693–700. 2014.
|
|
29
|
Shimizu D, Kanda M, Nomoto S, et al:
Identification of intragenic methylation in the TUSC1 gene as a
novel prognostic marker of hepatocellular carcinoma. Oncol Rep.
31:1305–1313. 2014.
|
|
30
|
Kanda M, Nomoto S, Oya H, et al:
Downregulation of DENND2D by promoter hypermethylation is
associated with early recurrence of hepatocellular carcinoma. Int J
Oncol. 44:44–52. 2014.
|
|
31
|
Kanda M, Shimizu D, Nomoto S, et al:
Prognostic impact of expression and methylation status of DENN/MADD
domain-containing protein 2D in gastric cancer. Gastric Cancer. Apr
3–2014.(Epub ahead of print). View Article : Google Scholar
|
|
32
|
Kawamura-Tsuzuku J, Suzuki T, Yoshida Y
and Yamamoto T: Nuclear localization of Tob is important for
regulation of its antiproliferative activity. Oncogene.
23:6630–6638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rodier A, Rochard P, Berthet C, et al:
Identification of functional domains involved in BTG1 cell
localization. Oncogene. 20:2691–2703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Winkler GS: The mammalian
anti-proliferative BTG/Tob protein family. J Cell Physiol.
222:66–72. 2010. View Article : Google Scholar
|
|
35
|
Buitenkamp TD, Pieters R, Zimmermann M, et
al: BTG1 deletions do not predict outcome in Down syndrome acute
lymphoblastic leukemia. Leukemia. 27:251–252. 2013. View Article : Google Scholar
|
|
36
|
Lee H, Cha S, Lee MS, Cho GJ, Choi WS and
Suk K: Role of antiproliferative B cell translocation gene-1 as an
apoptotic sensitizer in activation-induced cell death of brain
microglia. J Immunol. 171:5802–5811. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Waanders E, Scheijen B, van der Meer LT,
et al: The origin and nature of tightly clustered BTG1 deletions in
precursor B-cell acute lymphoblastic leukemia support a model of
multiclonal evolution. PLoS Genet. 8:e10025332012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Berthet C, Guéhenneux F, Revol V, et al:
Interaction of PRMT1 with BTG/TOB proteins in cell signalling:
molecular analysis and functional aspects. Genes Cells. 7:29–39.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Galen JC, Kuiper RP, van Emst L, et
al: BTG1 regulates glucocorticoid receptor autoinduction in acute
lymphoblastic leukemia. Blood. 115:4810–4819. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pal S and Sif S: Interplay between
chromatin remodelers and protein arginine methyltransferases. J
Cell Physiol. 213:306–315. 2007. View Article : Google Scholar : PubMed/NCBI
|
